Lenire is designed to fit into your schedule, treatment time is just 30-60 minutes daily from the comfort of your own home.
This is your first appointment. The purpose of your initial assessment is to determine if Lenire® is a suitable treatment option for you.
The assessment consists of a full clinical evaluation including a review of your medical, audiological, and tinnitus history. A full suite of audiological tests will be conducted by our specialist audiologist, along with a set of subjective tinnitus measurements. If further examination is required, Neuromod Medical may refer you on to an appropriate healthcare provider.
If Lenire is recommended as a treatment for you, a member of our team will then go through the device and treatment plan with you, supplying you with all of the relevant information, including the payment plans available.
At your second visit you will get your Lenire device. The purpose of this visit is to ensure you have a detailed understanding of how the device works and how to use it effectively at home.
Your device will be configured to your hearing profile before you arrive (based on information gathered at your initial visit) and a member of our team will calibrate your Tonguetip® during your visit. You will get a detailed overview of the Lenire system, its various components and how to safely store and clean your device.
As part of this visit, you will also be asked to use the device under the supervision of a member of our team. This is to ensure the configuration is comfortable and you are confident using the device before you go home.
Follow Up Visits
Over the course of your treatment, you will be asked to attend at least two follow up assessments in the clinic to assess your progress.
Typically, you will return for a visit after 6 to 12 weeks of using Lenire, during which a member of our team will review any changes in your audiological/tinnitus history and how you are managing the treatment. If necessary our audiologist may repeat audiological/ tinnitus tests. Your current treatment plan will be reviewed and your device may be reconfigured and tongue tip recalibrated if required. You will then return after another 6 to 12 weeks of using and the above measures will be repeated.
Lenire is not suitable for everyone. To ensure the safe use of the device there are a number of contraindications and warnings that your healthcare provider will consider prior to prescribing the treatment for you. If you have any of the contraindications specified below, your healthcare provider will not prescribe Lenire and will recommend an alternative treatment approach.
You should not use Lenire if:
You have a pacemaker, defibrillator or any other active implantable device
You are pregnant, unless directed by a doctor
You suffer from epilepsy or any other condition that may result in loss of consciousness
You suffer from any condition that causes impaired sensitivity of the tongue
You have lesions, sores or inflammation of the oral cavity
Lenire Fitting Range
Lenire® is calibrated to the unique hearing profile of each patient. At this time the device cannot be configured for patients with a hearing threshold (AC) in either ear of >40dBHL in the range of 250Hz – 1kHz or >80dBHL in the range of 2kHz- 8kHz. As a result, Lenire may not be suitable for hearing loss outside of this fitting range.